Table 2 Temporal trends in prevalence of physical activity counselling and effect estimates of stratified group comparisons

Men

0.84 (0.62–1.03)

Women

0.82 (0.65–1.02)

Men

Women

Men

Women

Total

(%)

OR (95 % CI)

(%)

OR (95 % CI)

(%)

OR (95 % CI)

(%)

OR (95 % CI)

OR (95 % CI)

BMI

 18.5 – <25.0

9.8

Ref.

9.4

Ref.

6.5

Ref.

6.2

Ref.

0.64*** (0.53–0.77)

 25.0 – <30.0

11.4

1.19 (0.86–1.63)

10.2

1.10 (0.81–1.49)

8.8

1.39 (0.94–2.08)

6.5

1.06 (0.73–1.53)

0.70** (0.54–0.91)

 30.0 +

12.2

1.29 (0.84–1.96)

7.8

0.82 (0.54–1.25)

15.1

2.56*** (1.67–3.93)

9.7

1.62* (1.08–2.42)

1.30 (0.92–1.82)

Diabetes

 No

11.1

Ref.

9.2

Ref.

8.6

Ref.

7.1

Ref.

0.76*** (0.65–0.88)

 Yes

10.8

0.97 (0.46–2.03)

9.8

1.08 (0.39–2.99)

29.8

4.51*** (2.54–8.01)

26.4

4.67*** (2.65–8.25)

3.42*** (1.68–6.96)

Coronary heart disease

 No

10.8

Ref.

9.2

Ref.

10.9

Ref.

8.5

Ref.

0.97 (0.80–1.17)

 Yes

17.7

1.77 (0.95–3.29)

9.2

1.01 (0.40–2.53)

24.0

2.56*** (1.54–4.27)

7.6

0.89 (0.24–3.26)

1.36 (0.68–2.72)

Hypertension

 No

10.6

Ref.

9.3

Ref.

8.1

Ref.

6.9

Ref.

0.73*** (0.62–0.86)

 Yes

14.1

1.39 (0.93–2.07)

8.4

0.89 (0.58–1.36)

16.8

2.29*** (1.64–3.21)

12.3

1.90** (1.30–2.79)

1.36 (0.97–1.90)

Cancer

 No

11.1

Ref.

9.1

Ref.

9.3

Ref.

7.6

Ref.

0.82* (0.71–0.96)

 Yes

9.0

0.79 (0.24–2.58)

10.2

1.13 (0.45–2.83)

14.0

1.59 (0.74–3.39)

8.2

1.08 (0.54–2.19)

1.05 (0.44–2.51)

Socio economic status (SES)

 Low

9.0

Ref.

7.7

Ref.

5.9

Ref.

6.4

Ref.

0.72 (0.47–1.11)

 middle

9.8

1.10 (0.70–1.72)

8.1

1.06 (0.70–1.62)

9.4

1.67 (0.93–2.98)

7.9

1.25 (0.75–2.08)

0.96 (0.79–1.18)

 High

15.6

1.86* (1.15–2.99)

14.4

2.03** (1.23–3.35)

12.0

2.18** (1.21–3.95)

8.1

1.28 (0.70–2.33)

0.64** (0.47–0.87)

Sports activity

 No sports

7.7

Ref.

5.4

Ref.

7.5

Ref.

7.2

Ref.

1.15 (0.85–1.55)

 <1 h/week

13.1

1.82* (1.14–2.89)

11.4

2.28*** (1.45–3.60)

10.7

1.49 (0.94–2.55)

6.4

0.89 (0.55–1.45)

0.67* (0.47–0.95)

 1–2 h/week

13.8

1.93** (1.29–2.88)

11.2

2.23*** (1.45–3.41)

11.1

1.55 (0.94–2.55)

10.3

1.47* (1.03–2.12)

0.85 (0.62–1.17)

 2–4 h/week

9.7

1.29 (0.83–2.00)

14.8

3.06*** (2.02–4.65)

10.3

1.42 (0.83–2.42)

6.5

0.89 (0.56–1.41)

0.67* (0.48–0.94)

 > 4 h/week

17.8

2.61*** (1.75–3.90)

17.1

3.65*** (1.99–6.68)

8.1

1.09 (0.63–1.88)

6.1

0.84 (0.46–1.51)

0.38*** (0.25–0.58)

Cardio-metabolic risk (score)

 normal risk (0–1)

10.5

Ref.

9.3

Ref.

7.8

Ref.

7.0

Ref.

0.73*** (0.62–0.85)

 elevated risk (2)

15.8

1.60* (1.07–2.40)

9.1

0.98 (0.60–1.58)

18.0

2.60*** (1.84–3.67)

11.4

1.72* (1.08–2.74)

1.22 (0.83–1.79)

 high risk (3)

5.1

0.46 (0.13–1.65)

11.1

1.22 (0.39–3.85)

31.2

5.37*** (2.42–11.89)

33.1

6.62*** (2.76–15.84)

5.33*** (1.89–15.00)